EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Sultams as Dual Inhibitors of Human Carbonic Anhydrase and Thioredoxin Reductase

Aleksandrs Pustenko iD, Raitis Bobrovs, Venkatesan Saravanan, Kathir Avan, Simone Carradori iD, Antons Sizovs, Andrea Angeli iD, Claudiu T Supuran iD, Raivis Žalubovskis

ChemMedChem · 29.07.2026 · 21 (14)

DOI: 10.1002/cmdc.70359 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 18.07.2026. Verfasst von Aleksandrs Pustenko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Latvian Institute of Organic Synthesis, Riga, Latvia. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Thioredoxin-Disulfide Reductase, Carbonic Anhydrases, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Recovery and Resilience Facility (RRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a leading cause of mortality, often complicated by drug resistance arising from single‐target therapies. Dual inhibitors that simultaneously target multiple cancer‐related defense mechanisms offer a promising strategy to overcome these limitations. Herein, we report the design, synthesis, and biological evaluation of a series of sultam‐based N ‐acyl derivatives ( 8a–k and 9a–k ) as potential dual inhibitors of thioredoxin reductase (TrxR1) and tumor‐associated carbonic anhydrases (CA IX and XII). TrxR1 screening identified a few active compounds, with inhibitory potency strongly influenced by the type and orientation of substituents. CA inhibition assays revealed pronounced selectivity for CA IX/XII, while off‐target isoforms CA I and CA II remained unaffected. These findings highlight the potential of sultam derivatives as dual‐targeting anticancer agents and provide a foundation for further optimization toward selective, multi‐pathway cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsThioredoxin-Disulfide ReductaseCarbonic AnhydrasesEnzyme InhibitorsAntineoplastic AgentsHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

biochemistrycancercancer therapycarbonic anhydrasecarbonic anhydrase Ichemistrydrug resistancegene isoformreductasethioredoxin reductase

Substanzen

Carbonic Anhydrase InhibitorsThioredoxin-Disulfide ReductaseCarbonic AnhydrasesEnzyme InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Latvian Institute of Organic Synthesis, Riga, Latvia.
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, India.
  • Department of Pharmacy, "G.d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
  • Baltic Biomaterials Centre of Excellence, Headquarters at Riga Technical University, Riga, Latvia.
  • Department of Neurofarba, Università degli Studi di Firenze, Florence, Italy.
  • Institute of Chemistry and Chemical Technology, Faculty of Natural Sciences and Technology, Riga Technical University, Riga, Latvia.

ORCID-Profile: Aleksandrs Pustenko, Simone Carradori, Andrea Angeli, Claudiu T Supuran

Förderung

  • Recovery and Resilience Facility (RRF)

Zitieren

APA

Pustenko, A., Bobrovs, R., Saravanan, V., Avan, K., Carradori, S., Sizovs, A., Angeli, A., Supuran, C. T., & Žalubovskis, R. (2026). Sultams as Dual Inhibitors of Human Carbonic Anhydrase and Thioredoxin Reductase. ChemMedChem, 21(14). https://doi.org/10.1002/cmdc.70359

Vancouver

Pustenko A, Bobrovs R, Saravanan V, Avan K, Carradori S, Sizovs A, et al. Sultams as Dual Inhibitors of Human Carbonic Anhydrase and Thioredoxin Reductase. ChemMedChem. 2026;21(14). doi:10.1002/cmdc.70359

BibTeX
@article{Pustenko2026,
  author = {Pustenko, Aleksandrs and Bobrovs, Raitis and Saravanan, Venkatesan and Avan, Kathir and Carradori, Simone and Sizovs, Antons and Angeli, Andrea and Supuran, Claudiu T and Žalubovskis, Raivis},
  title = {Sultams as Dual Inhibitors of Human Carbonic Anhydrase and Thioredoxin Reductase},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {14},
  doi = {10.1002/cmdc.70359}
}
Kostenlos starten →